The patients were diagnosed using the WHO criteria of post-COVID (long COVID) [52], namely: (a) individuals having a history of proven SARS-CoV-2 infection, (b) symptoms persisted beyond the acute phase of illness or manifested during recovery from acute COVID-19 infection, (c) symptoms lasted at least 2 months and are present 34 months after the onset of COVID-19, and (d) patients suffer from at least two symptoms that impair daily functioning including fatigue, memory or concentration problems, shortness of breath, chest pain, persistent cough, difficulty speaking, muscle aches, loss of smell or taste, affective symptoms, cognitive impairment, or fever [52]
The GSH system is the central antioxidant defense system in mammalian cells, including neurons and glia
Headaches or dizziness: Mild neurological side effects can occur, especially in those sensitive to peptides affecting neurotransmitter systems
Its role in preserving NAD+ and supporting mitochondrial health led to its use in advanced clinical longevity protocols as a tool to help protect NAD+
Histological analysis shows FOXO4-DRI eliminates FOXO4-positive senescent cells and reduces IL-6 expression in liver tissue, indicating resolution of chemotherapy-induced inflammatory damage
This study is one of the most rigorous ever conducted on topically applied GHK-Cu